Baltimore, MD – According to filings with the U.S. Securities and Exchange Commission, CoapTech is raising $8,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Howard Carolan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About CoapTech

CoapTech seeks to bring a series of breakthrough medical devices to worldwide markets, leveraging a patented, disruptive technology called Coaptive Ultrasound which is owned by the company. CoapTech devices will reduce health care costs, and improve safety, quality, patient experience, and access to services around the globe. Invented by Dr. Tropello, a critical care physician who was frustrated by the inefficiency of the current system, CoapTech delivers a novel platform technology combining magnetic attraction and low-cost, point-of-care ultrasound for visual feedback in diagnostic, interventional and therapeutic procedures.

To learn more about CoapTech, visit http://www.coaptech.com/

Contact:
Howard Carolan, Chief Executive Officer
443-745-1120
https://www.linkedin.com/in/howard-carolan/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved